Biotechnology in Leizig reproduces itself: Extension building Fraunhofer of the IZ had direction celebration

On 2 February 2011 the institute for Fraunhofer for cell therapy and Immunologie IZI celebrated the direction celebration first Erweiterungsbaus.Nachdem together with the companies taken part in the carcass on 23 September 2009 the foundation-stone for the first extension building for Fraunhofer the IZI was put, is now nearly completed its carcass. The building becomes from the outside and inside already now experiencable and continues the architecture of the main building. Architect and project manager Winfried Schmidbauer of the office Heinle, wiper and partner: We could be inspired with architecture of the smallest component of the human body � the cell . And thus the Fraunhofer buildings seem to be not symmetrically and rigidly, but, approximately organically and transparency. The extension building with a total area of 3,280 m � develops for main building Fraunhofer of the IZI and the BIO TOWN CENTER LEIPZIG on the old fairground between that. It permits by a connecting corridor in 3. Upper floor a direct entrance to the BIO TOWN CENTER LEIPZIG, where Institut already operates a modern pure space plant. On the individual levels of the daughter cell also a further pure space plant develops beside modern research laboratories and offices. Here in the future Zelltherapeutika and active substances are to be developed and be manufactured for the purpose of the clinical examination. In the medical-experimentally equipped laboratories used regeneration research and therapy developments are to be operated after the completion. Institute leader professor Frank Emmrich is pleased about the cultivation with the extension of our research infrastructure is now possible it us to work on substantially more extensive and more complex industrial orders . The delivery of the finished building is planned for the spring 2012. The total costs for the extension building amount to 8.6 million euros. The building is realized with the financial support of the European Union, the federation and the Free State Saxonia. The Fraunhofer Society operates application orientated research for the use of the economy and for the advantage of the society. In Germany at present more than 80 research establishments, of it 60 institutes, belong to it. More than 18,000 woman employees and coworker work on the annual research volume of 1.65 billion euros. Of it fall 1.40 billion euros on the capacity range contract research. The Fraunhofer Society with orders from the industry and with publicly financed research projects gains two thirds of this capacity range. Only one third is contributed from federation and countries as basic financing. The institute for Fraunhofer for cell therapy and Immunologie IZI is member Fraunhofer group of the Life Sciences. A goal of the institute is it, special problem solutions at the interfaces of medicine to find life sciences and engineer sciences for partners from the medicine-oriented industry and economy. The focus is thereby on the renewable medicine, i.e. with celltherapeutic beginnings for the re-establishment of function-disturbed fabrics and organs up to the biological replacement through into vitro bred fabrics (tissue engineering). So that the fabric without problems can increase, must cellular and immunological defense and control mechanisms to be seized and in the procedure and production development be integrated. Beyond that a multiplicity of tasks for new products and procedures result. Institut is oriented particularly hospital near and takes over quality inspections, GMP production of clinical test specimens and clinical studies on behalf. Beyond that it supports with the acquisition of manufacture permission and permissions.�

This text was translated automatically.